Mykor has secured £4 million in funding to scale its biotechnology platform, which converts agricultural and industrial waste into low-carbon building materials. The company focuses on prefabricated wall systems and insulation to reduce the embodied carbon of the construction industry. With over £338 million in commercial agreements across the UK and Europe, Mykor aims to integrate its mycelium-based materials into existing supply chains without requiring major operational changes for contractors.
